moxifloxacin has been researched along with tedizolid phosphate in 2 studies
Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (tedizolid phosphate) | Trials (tedizolid phosphate) | Recent Studies (post-2010) (tedizolid phosphate) |
---|---|---|---|---|---|
3,157 | 552 | 1,690 | 115 | 24 | 106 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fang, E; Flanagan, S; Litwin, J; Prokocimer, P | 1 |
Deshpande, D; Gumbo, T; Lee, PS; Pasipanodya, JG; Srivastava, S | 1 |
1 trial(s) available for moxifloxacin and tedizolid phosphate
Article | Year |
---|---|
Effects of therapeutic and supratherapeutic doses of oral tedizolid phosphate on cardiac repolarisation in healthy volunteers: a randomised controlled study.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoroquinolones; Healthy Volunteers; Heart Conduction System; Humans; Male; Middle Aged; Moxifloxacin; Organophosphates; Oxazoles; Placebos; Young Adult | 2016 |
1 other study(ies) available for moxifloxacin and tedizolid phosphate
Article | Year |
---|---|
A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Fluoroquinolones; Humans; Lung Diseases; Macrophages; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Organophosphates; Oxazoles; Rifabutin; THP-1 Cells | 2017 |